248 related articles for article (PubMed ID: 28335807)
1. Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study.
Nickler M; Ottiger M; Steuer C; Kutz A; Christ-Crain M; Zimmerli W; Thomann R; Hoess C; Henzen C; Bernasconi L; Huber A; Mueller B; Schuetz P;
Crit Care; 2017 Mar; 21(1):72. PubMed ID: 28335807
[TBL] [Abstract][Full Text] [Related]
2. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
[TBL] [Abstract][Full Text] [Related]
3. Dihydrotestosterone is a predictor for mortality in males with community-acquired pneumonia: results of a 6-year follow-up study.
Zurfluh S; Nickler M; Ottiger M; Steuer C; Kutz A; Christ-Crain M; Zimmerli W; Thomann R; Hoess C; Henzen C; Bernasconi L; Huber A; Mueller B; Schuetz P;
Respir Res; 2018 Dec; 19(1):240. PubMed ID: 30514319
[TBL] [Abstract][Full Text] [Related]
4. Changes in serum cortisol levels during community-acquired pneumonia: the influence of dexamethasone.
Remmelts HH; Meijvis SC; Kovaleva A; Biesma DH; Rijkers GT; Heijligenberg R
Respir Med; 2012 Jun; 106(6):905-8. PubMed ID: 22402329
[TBL] [Abstract][Full Text] [Related]
5. Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumonia.
Baumgartner T; Zurauskaité G; Wirz Y; Meier M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
BMC Infect Dis; 2018 Aug; 18(1):423. PubMed ID: 30143005
[TBL] [Abstract][Full Text] [Related]
6. Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study.
Alan M; Grolimund E; Kutz A; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Zimmerli W; Mueller B; Schuetz P;
J Intern Med; 2015 Aug; 278(2):174-84. PubMed ID: 25529395
[TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.
Ferrer M; Torres A; Martínez R; Ramírez P; Polverino E; Montull B; Sialer S; Niederman MS; Agusti A; Menéndez R
Respirology; 2014 Aug; 19(6):929-35. PubMed ID: 24909304
[TBL] [Abstract][Full Text] [Related]
8. Cytokines and Cortisol - predictors of treatment response to corticosteroids in community-acquired pneumonia?
Urwyler SA; Blum CA; Coslovsky M; Mueller B; Schuetz P; Christ-Crain M
J Intern Med; 2019 Jul; 286(1):75-87. PubMed ID: 30873676
[TBL] [Abstract][Full Text] [Related]
9. Activation of the tryptophan/serotonin pathway is associated with severity and predicts outcomes in pneumonia: results of a long-term cohort study.
Meier MA; Ottiger M; Vögeli A; Steuer C; Bernasconi L; Thomann R; Christ-Crain M; Henzen C; Hoess C; Zimmerli W; Huber A; Mueller B; Schuetz P
Clin Chem Lab Med; 2017 Jun; 55(7):1060-1069. PubMed ID: 28076309
[TBL] [Abstract][Full Text] [Related]
10. Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study.
Kolditz M; Höffken G; Martus P; Rohde G; Schütte H; Bals R; Suttorp N; Pletz MW;
BMC Infect Dis; 2012 Apr; 12():90. PubMed ID: 22501026
[TBL] [Abstract][Full Text] [Related]
11. Adrenal response in severe community-acquired pneumonia: impact on outcomes and disease severity.
Salluh JIF; Bozza FA; Soares M; Verdeal JCR; Castro-Faria-Neto HC; Lapa E Silva JR; Bozza PT
Chest; 2008 Nov; 134(5):947-954. PubMed ID: 18753464
[TBL] [Abstract][Full Text] [Related]
12. High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia.
Vestjens SMT; Spoorenberg SMC; Rijkers GT; Grutters JC; Ten Berg JM; Noordzij PG; Van de Garde EMW; Bos WJW;
Respirology; 2017 Jul; 22(5):1000-1006. PubMed ID: 28221010
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy.
Dörr HG; Heller A; Versmold HT; Sippell WG; Herrmann M; Bidlingmaier F; Knorr D
J Clin Endocrinol Metab; 1989 May; 68(5):863-8. PubMed ID: 2715289
[TBL] [Abstract][Full Text] [Related]
14. Association of adrenal function and disease severity in community-acquired pneumonia.
Mueller C; Blum CA; Trummler M; Stolz D; Bingisser R; Mueller C; Tamm M; Mueller B; Schuetz P; Christ-Crain M
PLoS One; 2014; 9(6):e99518. PubMed ID: 24910975
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D Status and Long-Term Mortality in Community-Acquired Pneumonia: Secondary Data Analysis from a Prospective Cohort.
Holter JC; Ueland T; Norseth J; Brunborg C; Frøland SS; Husebye E; Aukrust P; Heggelund L
PLoS One; 2016; 11(7):e0158536. PubMed ID: 27367810
[TBL] [Abstract][Full Text] [Related]
16. Association of adrenal hormone metabolites and mortality over a 6-year follow-up in COPD patients with acute exacerbation.
Zurfluh S; Nickler M; Ottiger M; Steuer C; Kutz A; Christ-Crain M; Zimmerli W; Thomann R; Hoess C; Henzen C; Bernasconi L; Huber A; Mueller B; Schuetz P
Clin Chem Lab Med; 2018 Mar; 56(4):669-680. PubMed ID: 29220883
[TBL] [Abstract][Full Text] [Related]
17. Time to antibiotics administration and outcome in community-acquired pneumonia: Secondary analysis of a randomized controlled trial.
Marti C; John G; Genné D; Prendki V; Rutschmann OT; Stirnemann J; Garin N
Eur J Intern Med; 2017 Sep; 43():58-61. PubMed ID: 28648477
[TBL] [Abstract][Full Text] [Related]
18. Cosyntropin testing does not predict response to glucocorticoids in community-acquired pneumonia in a randomized controlled trial.
Blum CA; Schuetz P; Nigro N; Winzeler B; Arici B; Refardt J; Urwyler SA; Rodondi N; Blum MR; Briel M; Mueller B; Christ-Crain M
Clin Endocrinol (Oxf); 2019 Sep; 91(3):374-382. PubMed ID: 30485501
[TBL] [Abstract][Full Text] [Related]
19. Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin.
Bello S; Fandos S; Lasierra AB; Mincholé E; Panadero C; Simon AL; Gavin O; De Pablo F; Menendez R; Torres A
Respir Med; 2015 Sep; 109(9):1193-206. PubMed ID: 26205553
[TBL] [Abstract][Full Text] [Related]
20. Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial.
Ebrahimi F; Giaglis S; Hahn S; Blum CA; Baumgartner C; Kutz A; van Breda SV; Mueller B; Schuetz P; Christ-Crain M; Hasler P
Eur Respir J; 2018 Apr; 51(4):. PubMed ID: 29519921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
